Transcriptional Interactions During Smallpox Infection and
  Identification of Early Infection Biomarkers by Valdivia-Granda, Willy A. et al.
TRANSCRIPTIONAL INTERACTIONS DURING SMALLPOX 
INFECTION AND IDENTIFICATION OF EARLY INFECTION 
BIOMARKERS*
WILLY A. VALDIVIA-GRANDA 
Orion Integrated Biosciences Inc.,  
265 Centre Ave. Suite 1R New Rochelle, NY 10805, USA 
Email: willy.valdivia@orionbiosciences.com 
 MARICEL G. KANN 
National Center for Biotechnology Information, National Institutes of Health,   
8600 Rockville Pike Bethesda, MD 20894, USA 
Email:kann@mail.nih.gov  
JOSE MALAGA 
Orion Integrated Biosciences Inc.,  
Email: jose.malaga@orionbiosciences.com
Smallpox is a deadly disease that can be intentionally reintroduced into the human population as a 
bioweapon. While host gene expression microarray profiling can be used to detect infection, the analysis 
of this information using unsupervised and supervised classification techniques can produce contradictory 
results. Here, we present a novel computational approach to incorporate molecular genome annotation 
features that are key for identifying early infection biomarkers (EIB). Our analysis identified 58 EIBs 
expressed in peripheral blood mononuclear cells (PBMCs) collected from 21 cynomolgus macaques 
(Macaca fascicularis) infected with two variola strains via aerosol and intravenous exposure. The level of 
expression of these EIBs was correlated with disease progression and severity. No overlap between the 
EIBs co-expression and protein interaction data reported in public databases was found. This suggests 
that a pathogen-specific re-organization of the gene expression and protein interaction networks occurs 
during infection. To identify potential genome-wide protein interactions between variola and humans, we 
performed a protein domain analysis of all smallpox and human proteins. We found that only 55 of the 
161 protein domains in smallpox are also present in the human genome. These co-occurring domains are 
mostly represented in proteins involved in blood coagulation, complement activation, angiogenesis, 
inflammation, and hormone transport. Several of these proteins are within the EIBs category and suggest 
potential new targets for the development of therapeutic countermeasures.  
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1.   INTRODUCTION 
The virus that causes smallpox, known as variola major, belongs to the genus 
Orthopoxvirus within the family Poxviridae. During 1967, the year the smallpox 
global eradication program began, an estimated 10 to 15 million smallpox cases 
occurred in 43 countries and caused the death of 2 million people annually (1). 
Intensive vaccination programs lead in 1979 to the eradication of the disease. Since 
then, vaccination ceased, and levels of immunity have dropped dramatically (2).  In 
recent years there has been increasing concern that this virus can be used as a 
bioweapon (3, 4). 
In very early stages of viral infection and during the progression of the disease, 
a series of physiological and molecular changes including differential gene 
expression occur in the host. This information can be used to identify biomarkers 
correlated with the presence or absence of a specific pathogen, the prognosis of the 
disease, or the efficacy of vaccines and drug therapies. Since microarrays can 
measure the whole genome gene expression profiles, the use of peripheral blood 
mononuclear cells (PBMCs) can allow the identification of pathogen-specific 
biomarkers before clinical symptoms appear.  
While the collection of PBMCs is a minimal invasive method which facilitates 
the assessment of host responses to infection, doubts about their usefulness persist. 
These revolve around two very strong arguments. First, expression signals might 
come from a minority of cells within the bloodstream. Thus, expression might be a 
secondary consequence rather a primary effect of viral infection. Second, PBMC 
population is not in a homogenous biological state; therefore, there is an inherent 
biological noise which could make the data impossible to reproduce. 
Rubins et al. (5) used cDNA microarrays to measure the expression changes 
occurring in PBMCs collected from blood of cynomolgus macaques infected with 
two strains of variola by aerosol and intravenous exposure. Clustering analyses 
revealed that variola infection induced the expression of genes involved in cell 
cycle and proliferation, DNA replication, and chromosome segregation. These 
transcriptional changes were attributed to the fact that poxviruses encode 
homologues of the mammalian epidermal growth factor (EGF) that bind ErbB 
protein family members which are potent stimulators of cell proliferation. However, 
the conclusions of Rubins et al. (5) were limited by the ability of unsupervised 
microarray data analysis algorithms, such as clustering, to detect true gene product 
interactions (6, 7). This is relevant, because an increasing number of data suggests 
that proteins involved in the regulation of cellular events resulting from viral 
infections are organized in a modular fashion rather in a particular class or cluster 
(8-10).  
While some microarray data analysis tools use gene ontologies to increase the 
performance of the classification of gene expression data (11, 12), these methods 
incorporate molecular annotation after the classification of the gene expression 
values. However, many human genes have little or no functional annotation, or they 
have multiple molecular functions that can change with database update versions. 
Therefore, the identification of biomarkers is challenging because it is not possible 
to quantify the contribution of the molecular annotation in the overall classification 
process. To address these limitations, and to gain a better understanding of the 
molecular complexity resulting during host-pathogen interactions, we developed a 
new method for microarray data classification and for the discovery of early 
infection biomarkers (EIBs). Our approach incorporates different molecular 
biological datasets and narrows the set of attributes required for the classification 
process. This information is represented as transcriptional networks where genes 
associated with early viral infection events and disease severity are selected. These 
interactions were overlapped with physical protein-protein interaction data reported 
in the scientific literature. To complement these analyses and to identify possible 
human receptors used by smallpox during cellular entry, replication, assembly, and 
budding (13, 14), we identified all protein domains (from PFAM protein domain 
database (15)) within 197 smallpox proteins that are also present within human 
proteins. The results of our analysis provide new insights into receptor co-evolution 
and suggest potential therapeutic targets that might diminish the lethal 
manifestations of smallpox.  
2.   METHODS 
2.1.   Transcriptional Network Reconstruction 
We used the microarray gene expression data from the experiments by Rubins 
et al. (5). This information consists of the molecular profiles collected from PBMCs 
of 21 male cynomolgus macaques (Macaca fascicularis) exposed to two variola 
strains (India-7124 and Harper-99) via subcutaneous injections (5 X 108 plaque-
forming-units p.f.u.) and aerosol exposure (109 p.f.u.). For the analysis of this data, 
we developed an algorithm to identify genes responding similarly to the viral 
challenge across different exposed animals. Then we proceeded  to identify 
infection specific genes corresponding to a particular time-point after the 
inoculation (16). As shown in Figure 1, our implementation consists of two main 
steps. First, a nearest neighbor voting (NNV) classification including gene 
expression values and gene annotation features where the best attributes associated 
to a particular transcriptional network are selected (17). Second, a genetic algorithm 
(GA) optimization using the trade off between the false negative and false positive 
rates for every possible function cut off area, represented by the area under the 
receiver operating characteristic (ROC) curve, as fitness function (17).  
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Equation 1.1 defines the function used for predictor voting (Pred) of specific 
transcriptional interactions, estimated as the sum of the similarity importance for a 
given gene G (Im(G)) and the similarity of attributes (Sim(G)) of its gene 
neighbors. The gene importance of gene G is given by Equation 1.2 and is based on 
the weights for scoring the gene cellular compartment localization (WL), number of 
interactions with other genes (WI), and number of attributes (WA).  Considering that 
there are multiple attributes to select, we optimized the weight space (Wtf) (used in 
Equation 1.3) by scoring the best combination of weights using a standard genetic 
algorithm (GA) matching each of the features (f) voted as important. This approach 
selects the best and/or fittest solution and allows only the higher scores to proceed 
in form of transcriptional interactions. The ROC value of the prediction is used as 
the fitness evaluator. Depending on the fitness value, random mutation is used 
occasionally to change or optimize an existing solution. For the visualization of the 
final transcriptional interactions we calculated the probability (p<0.01) of the 
network composition defined by hyper geometric distribution, as shown in Equation 
2: 
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where N is the total number of elements represented in our dataset (~18,000),  r is 
the total number of those that are part of a transcriptional network, n is the number 
of differentially expressed genes that belong to the transcriptional network, and y is 
the number of differentially expressed genes members of a smallpox day-specific 
event. This information is represented as transcriptional networks at cellular 
localization, molecular function and biological process levels. 
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Fig. 1. Overall implementation of the computational analysis of the microarray data, the EIBs 
identification and the transcriptional network reconstruction. First, we implemented a genomic 
catalog where each gene annotation feature (e.g. GO, KEGG) is joined with gene expression 
values. Then, the nearest neighborhood voting (NNV) algorithm selects gene transcriptional 
interactions based on a genetic algorithm (GA) using the ROC curves as fitness function.  
2.2.   Overlapping of Gene Expression Networks and PPis 
After the formation of specific gene expression transcriptional interactions we 
used the Information Hyperlinked over Proteins (iHOP) database (18, 19) and the 
Human Protein Reference Database (HPRD) (20) to identify and retrieve physical 
and in-vitro protein interactions reported in the scientific literature.  
2.3.   Smallpox-Human Protein Domain Analysis 
     To determine the level of co-occurrence of protein domains in smallpox and 
humans, we use HMMer version 2.3.2 to query the PFAM protein domain database 
release 19 (15) against the 197 proteins coded by the smallpox genome and all the 
human proteins from Genbank (21). All PFAM domains with statistically 
significant hits (E-value cutoff ≤ 1e-03) to the smallpox proteins were used to 
create the smallpox-pfam protein domain database. The same procedure was applied 
to the set of human proteins to derive the human-pfam database. From the 
comparison of the smallpox-pfam and human-pfam we derived a set of protein 
domains that co-occur in both organisms. We constructed a protein interaction 
network based on protein domain present in variola and human. In such network, 
the nodes represent all human and variola proteins and the edges between two 
proteins (one from each organism) are drawn when they share at least one domain 
among them. All proteins without any edges were excluded from the analysis 
resulting in a network containing only proteins with shared domains. 
3.   RESULTS 
3.1.   PBMCs Gene Patterns as Early Infection Biomarkers  
Our re-analysis of more than 5.5 million data points, including 18,000 human 
genes, identified a transcriptional network that represented early infection 
biomarkers (EIB) with gene profile patterns similar across the animals used in this 
study (Table 1). The level of expression of these EIB coincided with disease 
severity (Figure 2). This transcriptional network is composed of 58 gene functions, 
23 representing membrane receptors, signal transduction, and cell differentiation 
pathways involved in cell to cell communication, DNA binding and repair, as well 
as immune responses (Figure 3).  
 
Table 1.  List of main human genes and clones considered as smallpox EIBs. 
ZFP276Zinc finger protein 276 homolog (mouse)IMAGE:42402
—Transcribed locusIMAGE:430169
PPP2R5DProtein phosphatase 2, regulatory subunit, delta isoformIMAGE:429029
PARP1Poly (ADP-ribose) polymerase family, member 1IMAGE:200409
PYGLPhosphorylase, glycogen; liver (Hers disease)IMAGE:2435216
PYGLPhosphorylase, glycogen; liverIMAGE:505573
MADMAX dimerization protein 1IMAGE:223176
LCN2Lipocalin 2 (oncogene 24p3)IMAGE:741497
IL13Interleukin 13IMAGE:1837472
—In multiple clustersIMAGE:564325
HPHaptoglobinIMAGE:2508044
GCAGrancalcin, EF-hand calcium binding proteinIMAGE:684912
QPCTGlutaminyl-peptide cyclotransferase (glutaminyl cyclase)IMAGE:711918
ENTPD3Ectonucleoside triphosphate diphosphohydrolase 3IMAGE:1881815
DYSFDysferlin, limb girdle muscular dystrophy IMAGE:1914863
DHRS9Dehydrogenase/reductase (SDR family) member 9IMAGE:814655
CDACytidine deaminaseIMAGE:1552797
CDACytidine deaminaseIMAGE:1551030
CTSGCathepsin GIMAGE:2248876
CEACAM1Carcinoembryonic antigen-related cell adhesion molecule 1IMAGE:1881943
BPIBactericidal/permeability-increasing proteinIMAGE:730433
ATMAtaxia telangiectasiaIMAGE:186945
ALOX5APArachidonate 5-lipoxygenase-activating proteinIMAGE:67759
ALOX5Arachidonate 5-lipoxygenaseIMAGE:2020917
ALPLAlkaline phosphatase, liver/bone/kidneyIMAGE:1271662
ACSL1Acyl-CoA synthetase long-chain family member 1IMAGE:2014138
ACSL1Acyl-CoA synthetase long-chain family member 1IMAGE:82734
SYMBOLGENE NAMECLONE ID
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Gene expression patterns of EIBs associated with different stages of disease severity 
uniformly co-expressed across 21 cynomolgus macaques (Macaca fascicularis). Darker 
intensities depict higher gene expression and disease severity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Molecular function representation of transcriptional networks considered as EIBs.   
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3.2.   Protein-Protein and Gene Expression Interactions:  
We expected to find a small number of genes reported as physically interacting 
proteins to be co-expressed in the gene expression matrix; however, we were find 
how no correlation between transcriptional and proteomic levels (Figure 4a and 4b). 
Even when we retrieved the expression of genes reported to be physically 
interacting (Figure 4b), their gene expression profiles were down regulated in both 
control and treated animals and did not provide any discriminative information 
(data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4a. Gene transcriptional co-expression.  Figure 4b. Protein-protein physical interaction  
data. 
 
3.3.   Protein Domain Comparison between Human and Smallpox 
Our analysis uncovered 161 PFAM domains present in smallpox proteins. 
From those, only 55 are also present in humans. The structure of the protein domain 
network displays a scale-free structure (Figure 5). In humans, these domains 
participate in biological processes such as blood coagulation, complement 
activation, fibrinolysis, angiogenesis, inflammation, tumor suppression, and 
hormone transport. For example, the immunoglobulin V-set domain family was 
represented in 339 different human proteins serving as several T-cell receptors such 
as CD2, CD4, CD80, and CD86. Also, 24 proteins humans contain the TNFR_c6 
PFAM domain that is a co-stimulatory signal for T and B cell activation and is 
involved in T cell development.  
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Fig. 5. Top PFAM motifs hit distribution in humans and variola major virus. 
 
4.   DISCUSSION 
Until this report the analysis of microarray data was performed using either 
clustering or classification algorithms. These approaches did not consider the 
biological annotation available for each of the gene or incorporated this information 
after the analysis (10, 22). Instead, our analysis determined simultaneously the 
importance of each gene and their likelihood of interaction based on the gene 
expression values as well as in different annotation features available in several 
databases. In this work, we identified a specific set of genes with a transcriptional 
state (on/off) associated with the health condition of the animals exposed to variola. 
These patterns are independent of strain or the type of exposure (aerosol or 
intravenous) used in these experiments (5, 16). Despite our success, we believe that 
in order to truly identify EIBs it is necessary to collect transcriptional information 
as early as 6 hours after pathogen exposure. Nonetheless, our comparison of the 
smallpox EIB transcriptional network against other experiments using RNA viral 
infections suggests that EIBs reported here are specific for smallpox exposure (data 
not shown). 
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Detailed analysis of the molecular function of each EIB revealed their 
participation in multiple biological processes. For example, the protein encoded by 
the ataxia-telangiectasia mutated (ATM) gene is phosphatidylinositol-3 kinase 
involved in cancer predisposition and radiation sensitivity (23, 24). This gene 
regulates DNA repair, apoptosis, cell cycle and toll-like receptor signaling (25). 
The encoded protein by carcinoembryonic antigen-related cell adhesion molecule 1 
precursor (CEACAM1) gene is a cell-cell adhesion molecule that is found in 
leukocytes, epithelia, endothelia, neutrophils, monocytes, macrophages, B and T 
lymphocytes. This protein has roles in the differentiation and arrangement of tissue 
three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, 
and the modulation of innate and adaptive immune responses.  Haptoglobin (Hp) is 
a regulator of the Th1/Th2 balance and exhibits a dose-dependent inhibitory effect 
on human T lymphocyte release of the Th2 cytokines (IL-4, IL-5, IL-10 and IL-13).  
Distinct biological roles, and the fact that there is no correlation between EIBs 
co-expression and protein interaction data reported in the literature, points to two 
main modes of host-viral interactions. First, since smallpox can manipulate immune 
response mechanisms (26, 27), it is plausible that the host activates alternative viral 
defense responses including the EIB reported here. Second, it is possible that 
smallpox proteins regulate the expression of the EIBs and use these protein 
products to complete a specific biological process. Since the level of up-regulation 
of EIBs was related to disease severity, and many of these human genes are 
involved in DNA repair and carcinogenesis (a feature known to be used by variola 
viruses), it is more likely that the pathogen takes advantage of these proteins to 
complete key biological processes. Protein motif profiling of the complete human 
and smallpox genomes reveals that 111 PFAM domains are specific for smallpox 
and are present mostly in one viral protein. In addition, 55 domains present in 
smallpox are also shared between different human protein families involved in key 
regulatory process such are interferon inhibitors, blood coagulation, inflammation, 
tumor suppression and T-cell differentiation. Several of these domains were present 
in our EIBs, thus suggesting that smallpox regulates host gene expression and that 
the virus protein-host protein interaction might result in a better viral cellular entry, 
replication and budding. It is also plausible that smallpox proteins block human 
proteins involved in immune responses. 
5.   CONCLUSIONS: 
We presented a new computational analysis utilizing microarray gene 
expression data and molecular annotation to identify infection biomarkers 
potentially specific to variola major. Results of the weight optimization of the 
features associated can be useful in giving researchers an indication of what defines 
a particular transcriptional network during pathogen infection. Overall, our 
approach uncovered a set of genes associated with disease severity and progression 
independent of the variola strains or the type of exposure used for the challenge. 
The profiling of PFAM domains also pointed to the possibility of variola utilizing 
specific host gene products to complete key biological processes. These results have 
important implications in diagnostics, vaccine efficacy assessment, and 
development of therapeutic countermeasures. 
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